Trial Profile
Platelet response after discontinuation of eltrombopag in Spanish Eltrombopag Registry patients with chronic immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Apr 2015
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 21 Apr 2015 New trial record